Cargando…
May lamotrigine be an alternative to topiramate in the prevention of migraine with aura? Results of a retrospective study
BACKGROUND: Evidence suggests that lamotrigine could be effective in reducing aura frequency and duration. However, studies comparing lamotrigine to other, first-line prophylactic agents solely involving patients suffering from migraine with aura are still lacking. The aim of this study was to compa...
Autores principales: | Smeralda, Carmelo Luca, Gigli, Gian Luigi, Janes, Francesco, Valente, Mariarosaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871707/ https://www.ncbi.nlm.nih.gov/pubmed/33681794 http://dx.doi.org/10.1136/bmjno-2020-000059 |
Ejemplares similares
-
Clinical and Neurophysiological Effects of Botulinum Neurotoxin Type A in Chronic Migraine
por: Valente, Mariarosaria, et al.
Publicado: (2021) -
A comparative study on the effectiveness of topiramate and propranolol in patients with migraine with aura
por: Mohammadianinejad, Seyed Ehsan, et al.
Publicado: (2022) -
Supersaturation of VEP in Migraine without Aura Patients Treated with Topiramate: An Anatomo-Functional Biomarker of the Disease
por: De Luca, Ciro, et al.
Publicado: (2021) -
Topiramate in migraine progression
por: Ruiz, Luigi, et al.
Publicado: (2009) -
To Treat or Not to Treat: Importance of Functional Dependence in Deciding Intravenous Thrombolysis of “Mild Stroke” Patients
por: Merlino, Giovanni, et al.
Publicado: (2020)